Do you want to read an article? Please log in or register.
Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma
Melanoma and Skin Cancer
Related content
Melanoma and Skin Cancer
Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma
JAMA Dermatol.
Calomarde-Rees L, García-Calatayud R, Requena Caballero C, Manrique-Silva E, Traves V, García-Casado Z, Soriano V, Kumar R, Nagore E
doi: 10.1001/jamadermatol.
COMMENTED
Melanoma and Skin Cancer
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy
JAMA Dermatol.
Sun L, Chin RI, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT, Koyfman SA, Manyam BV
doi: 10.1001/jamadermatol.
Melanoma and Skin Cancer
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib
Eur J Cancer
Saiag P, Robert C, Grob JJ, Mortier L, Dereure O, Lebbe C, Mansard S, Grange F, Neidhardt EM, Lesimple T, Machet L, Bedane C, Maillard H, Dalac-Rat S, Nardin C, Szenik A, Denden A, Dutriaux C
doi: 10.1016/j.ejca.2021.05.031
Melanoma and Skin Cancer
Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities
★ 2
Recommended by
Alexander Meisel, Faculty Member
JAMA Dermatol
Demer AM, Hanson JL, Maher IA, Liszewski W
doi: 10.1001/jamadermatol.2020.3950
Melanoma and Skin Cancer
Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins
JAMA Dermatol.
Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, Ferris LK, Nguyen J, Trofymenko O, Liu Y, Chen SC, Pigmented Lesion Subcommittee, Melanoma Prevention Working Group
doi: 10.1001/jamadermatol.
Melanoma and Skin CancerT Cells
Decline of PD-1 positive circulating T regulatory cells predicting more favorable clinical outcome of melanoma patients under immune checkpoint blockade
Br J Dermatol.
Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC
doi: 10.1111/bjd.18379.
Melanoma and Skin Cancer
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial
Lancet.
Utjés D, Malmstedt J, Teras J, Drzewiecki K, Gullestad HP, Ingvar C, Eriksson H, Gillgren P
doi: 10.1016/S0140-6736(19)31132-8.
Melanoma and Skin Cancer
Solar Lentigines are Associated with Better Outcome in Cutaneous Melanoma
Acta Derm Venereol.
Marasigan V, Güvenç C, Oord JJ, Stas M, Boecxstaens V, Bechter O, Wolter P, Lambrechts D, Garmyn M
doi: 10.2340/00015555-
RECOMMENDED
Melanoma and Skin Cancer
Comparison of Survival Between Patients With Single vs Multiple Primary Cutaneous Melanomas
JAMA Dermatol.
El Sharouni MA, Witkamp AJ, Sigurdsson V, van Diest PJ
doi: 10.1001/jamadermatol.